Diagnosis and management of pulmonary hypertension in patients with CKD

CP Walther, V Nambi, NA Hanania… - American Journal of …, 2020 - Elsevier
Pulmonary hypertension (PH) is a highly prevalent and important condition in adults with
chronic kidney disease (CKD). In this review, we summarize the definition of PH, discuss its …

Obesity, preserved ejection fraction heart failure, and left ventricular remodeling

J Stencel, HR Alai, A Dhore-Patil… - Journal of Clinical …, 2023 - mdpi.com
Owing to the overwhelming obesity epidemic, preserved ejection fraction heart failure
commonly ensues in patients with severe obesity and the obese phenotype of preserved …

Application of diagnostic algorithms for heart failure with preserved ejection fraction to the community

S Selvaraj, PL Myhre, M Vaduganathan, BL Claggett… - Heart Failure, 2020 - jacc.org
Objectives This study sought to describe characteristics and risk of adverse outcomes
associated with the H2FPEF and HFA-PEFF scores among participants in the community …

Changes in pulmonary artery pressure late in life: the Atherosclerosis Risk in Communities (ARIC) study

R Zierath, B Claggett, V Arthur, Y Yang, H Skali… - Journal of the American …, 2023 - jacc.org
Background Although the prognostic implications of higher pulmonary artery systolic
pressure (PASP) are well established, few data exist regarding longitudinal change in …

The potential of cystatin C as a predictive biomarker in pulmonary hypertension

A Duan, Z Huang, Z Zhao, Q Zhao, Q Jin, L Yan… - BMC Pulmonary …, 2023 - Springer
Background Cystatin C is a novel biomarker to identify renal dysfunction and cardiovascular
risk. Objective The aim of this study was to investigate the role of cystatin C in non-invasive …

Nephrectomy and high-salt diet inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in rats

Q Jiang, Q Yang, C Zhang, C Hou, W Hong, M Du… - Respiratory …, 2024 - Springer
Background Chronic kidney disease (CKD) is a significant risk factor for pulmonary
hypertension (PH), a complication that adversely affects patient prognosis. However, the …

Biomarkers in pulmonary hypertension

AM Marra, E Bossone, A Salzano… - Heart failure …, 2018 - heartfailure.theclinics.com
The term biomarkers basically refers to humoral laboratory-measured molecules,“A
characteristic that is objectively measured and evaluated as an indicator of normal biological …

[HTML][HTML] Early acute kidney injury after transcatheter aortic valve implantation: Predictive value of currently available risk scores

F Loizzi, O Burattini, A Cafaro, F Spione… - Hellenic Journal of …, 2023 - Elsevier
Background Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is a
frequent complication associated with adverse outcomes and mortality. Various scores have …

The prevalence of pulmonary hypertension among maintenance dialysis patients with ESRD and its associated factors: a retrospective study

Y Zhang, XH Ding, R Rao, Y Wang, F Pang… - Frontiers in …, 2020 - frontiersin.org
Aim: To determine the prevalence of pulmonary hypertension (PH) and its associated factors
among end-stage renal disease (ESRD) patients who underwent maintenance dialysis …

Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis

W Shang, Y Li, Y Ren, W Li, HL Wei, J Dong - International urology and …, 2018 - Springer
Purpose Recent epidemiological evidence attempts to demonstrate the risk of pulmonary
hypertension (PH) among patients with chronic kidney disease (CKD) without dialysis, but …